Lead placement for deep brain stimulation (DBS) using intraoperative MRI (iMRI) relies solely on real-time intraoperative neuroimaging to guide electrode placement, without microelectrode recording (MER) or electrical stimulation. There is limited information, however, on outcomes after iMRI-guided DBS for dystonia. The authors evaluated clinical outcomes and targeting accuracy in patients with dystonia who underwent lead placement using an iMRI targeting platform.
Patients with dystonia undergoing iMRI-guided lead placement in the globus pallidus pars internus (GPi) were identified. Patients with a prior ablative or MER-guided procedure were excluded from clinical outcomes analysis. Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) scores and Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) scores were assessed preoperatively and at 6 and 12 months postoperatively. Other measures analyzed include lead accuracy, complications/adverse events, and stimulation parameters.
A total of 60 leads were implanted in 30 patients. Stereotactic lead accuracy in the axial plane was 0.93 ± 0.12 mm from the intended target. Nineteen patients (idiopathic focal, n = 7; idiopathic segmental, n = 5; DYT1, n = 1; tardive, n = 2; other secondary, n = 4) were included in clinical outcomes analysis. The mean improvement in BFMDRS score was 51.9% ± 9.7% at 6 months and 63.4% ± 8.0% at 1 year. TWSTRS scores in patients with predominant cervical dystonia (n = 13) improved by 53.3% ± 10.5% at 6 months and 67.6% ± 9.0% at 1 year. Serious complications occurred in 6 patients (20%), involving 8 of 60 implanted leads (13.3%). The rate of serious complications across all patients undergoing iMRI-guided DBS at the authors’ institution was further reviewed, including an additional 53 patients undergoing GPi-DBS for Parkinson disease. In this expanded cohort, serious complications occurred in 11 patients (13.3%) involving 15 leads (10.1%).
Intraoperative MRI–guided lead placement in patients with dystonia showed improvement in clinical outcomes comparable to previously reported results using awake MER-guided lead placement. The accuracy of lead placement was high, and the procedure was well tolerated in the majority of patients. However, a number of patients experienced serious adverse events that were attributable to the introduction of a novel technique into a busy neurosurgical practice, and which led to the revision of protocols, product inserts, and on-site training.
ABBREVIATIONSBFMDRS = Burke-Fahn-Marsden Dystonia Rating Scale; CD = cervical dystonia; CI = confidence interval; CP = cerebral palsy; DBS = deep brain stimulation; GPi = globus pallidus pars internus; ICL = intercommissural line; iMRI = intraoperative MRI; IPG = internal pulse generator; MCP = midcommissural point; MER = microelectrode recording; PD = Parkinson disease; QSM = quantitative susceptibility mapping; SAE = serious adverse event; SEM = standard error of the mean; STN = subthalamic nucleus; TWSTRS = Toronto Western Spasmodic Torticollis Rating Scale.
Correspondence Robert E. Gross: Emory University School of Medicine, Atlanta, GA. firstname.lastname@example.org.INCLUDE WHEN CITING Published online October 11, 2019; DOI: 10.3171/2019.6.JNS19548.
V.D.S. and Y.B.B. contributed equally to this work.
Disclosures Dr. Willie received consulting fees from Medtronic, MRI Interventions, Neuropace, and NICO Medical, and research support from Medtronic and Neuropace. Dr. Factor has received honoraria from Biogen, Lundbeck, Teva, Sunovion, Acadia, Neuroderm, Acorda, CereSpir, and Bracket; received grants from Ipsen, Medtronic, Boston Scientific, Teva, US World Meds, Sunovion Therapeutics, Vaccinex, Voyager, Jazz Pharmaceuticals, the CHDI Foundation, the Michael J. Fox Foundation, and NIH (no. U10 NS077366); and received royalties from Demos, Blackwell Futura for textbooks, Springer, and Uptodate. Dr. Boulis is a consultant for Disarm, Axovant Sciences, PTC, Aruna, BlueRock Therapeutics LP, NeuralStem, and Voyager, and is on the Scientific Advisory Board for Renew Biopharma Inc. and CODA. Dr. Gross received consulting fees from Medtronic, St. Jude Medical, MRI Interventions, Abbott, and Boston Scientific, and a research grant from Medtronic and Boston Scientific (these arrangements were approved by Emory University).
AndrewsC, Aviles-OlmosI, HarizM, FoltynieT: Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes. 81:1383–1389, 201010.1136/jnnp.2010.20799320841370)| false
BandtSKde RochefortLChenWDimovAVSpincemaillePKopellBH: Clinical integration of quantitative susceptibility mapping magnetic resonance imaging into neurosurgical practice. World Neurosurg122:e10–e192019
ComellaCL, StebbinsGT, GoetzCG, ChmuraTA, BressmanSB, LangAE: Teaching tape for the motor section of the Toronto Western Spasmodic Torticollis Scale. 12:570–575, 1997925107610.1002/mds.870120414)| false
GeevargheseRO’Gorman TuuraRLumsdenDESamuelMAshkanK: Registration accuracy of CT/MRI fusion for localisation of deep brain stimulation electrode position: an imaging study and systematic review. Stereotact Funct Neurosurg94:159–1632016
GeevargheseR, O’Gorman TuuraR, LumsdenDE, SamuelM, AshkanK: Registration accuracy of CT/MRI fusion for localisation of deep brain stimulation electrode position: an imaging study and systematic review. 94:159–163, 201610.1159/00044660927318464)| false
GrossRE, KrackP, Rodriguez-OrozMC, RezaiAR, BenabidAL: Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson’s disease and tremor. 21 (Suppl 14):S259–S283, 200610.1002/mds.20960)| false
HamidNAMitchellRDMocroftPWestbyGWMilnerJPallH: Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement. J Neurol Neurosurg Psychiatry76:409–4142005
HamidNA, MitchellRD, MocroftP, WestbyGW, MilnerJ, PallH: Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement. 76:409–414, 200510.1136/jnnp.2003.03202915716537)| false
KissZH, Doig-BeyaertK, EliasziwM, TsuiJ, HaffendenA, SuchowerskyO: The Canadian multicentre study of deep brain stimulation for cervical dystonia. 130:2879–2886, 20071790579610.1093/brain/awm229)| false
LarsonPSStarrPABatesGTanseyLRichardsonRMMartinAJ: An optimized system for interventional magnetic resonance imaging-guided stereotactic surgery: preliminary evaluation of targeting accuracy. Neurosurgery70 (1 Suppl Operative):95–1032012
MartinAJ, LarsonPS, OstremJL, Keith SootsmanW, TalkeP, WeberOM, : Placement of deep brain stimulator electrodes using real-time high-field interventional magnetic resonance imaging. 54:1107–1114, 200510.1002/mrm.2067516206144)| false
NakajimaTZrinzoLFoltynieTOlmosIATaylorCHarizMI: MRI-guided subthalamic nucleus deep brain stimulation without microelectrode recording: can we dispense with surgery under local anaesthesia?Stereotact Funct Neurosurg89:318–3252011
NakajimaT, ZrinzoL, FoltynieT, OlmosIA, TaylorC, HarizMI, : MRI-guided subthalamic nucleus deep brain stimulation without microelectrode recording: can we dispense with surgery under local anaesthesia?89:318–325, 201110.1159/00033037921921673)| false
OstremJLGalifianakisNBMarkunLCGraceJKMartinAJStarrPA: Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg115:708–7122013
OstremJL, ZimanN, GalifianakisNB, StarrPA, LucianoMS, KatzM, : Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson’s disease. 124:908–916, 201610.3171/2015.4.JNS1517326495947)| false
RolstonJD, EnglotDJ, StarrPA, LarsonPS: An unexpectedly high rate of revisions and removals in deep brain stimulation surgery: Analysis of multiple databases. 33:72–77, 201610.1016/j.parkreldis.2016.09.01427645504)| false
StarrPAChristineCWTheodosopoulosPVLindseyNByrdDMosleyA: Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic imaging–verified electrode lead locations. J Neurosurg97:370–3872002
StarrPA, ChristineCW, TheodosopoulosPV, LindseyN, ByrdD, MosleyA, : Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic imaging–verified electrode lead locations. 97:370–387, 200210.3171/jns.2002.97.2.037012186466)| false
StarrPA, MarkunLC, LarsonPS, VolzMM, MartinAJ, OstremJL: Interventional MRI-guided deep brain stimulation in pediatric dystonia: first experience with the ClearPoint system. 14:400–408, 20142508408810.3171/2014.6.PEDS13605)| false
StarrPAMartinAJOstremJLTalkePLevesqueNLarsonPS: Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. J Neurosurg112:479–4902010
StarrPA, MartinAJ, OstremJL, TalkeP, LevesqueN, LarsonPS: Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy. 112:479–490, 201010.3171/2009.6.JNS081161)| false
ValldeoriolaFRegidorIMínguez-CastellanosALezcanoEGarcía-RuizPRojoA: Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. J Neurol Neurosurg Psychiatry81:65–692010
ValldeoriolaF, RegidorI, Mínguez-CastellanosA, LezcanoE, García-RuizP, RojoA, : Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study. 81:65–69, 201010.1136/jnnp.2009.17434219744963)| false
ZrinzoL, FoltynieT, LimousinP, HarizMI: Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. 116:84–94, 20122190579810.3171/2011.8.JNS101407)| false